| 联系我们 |
|
欢迎联系客服人员：
客服：13918293035
QQ：3001034031
客服：13917991872
QQ：3001005926
客服：15102117276
QQ：3001090745
客服：18217024652
QQ：3001084617
客服：13816009161
QQ：3001086693
客服：13795317828
QQ：3001080377
客服：15800340161
QQ：3001010259
客服：13651665725
QQ：3001028570
客服：18918753302
QQ：3001080321
客服：13916577892
QQ：3001007248
客服：15316187026
QQ：3004961006
客服：18901678489
QQ：3004909899
客服：18018502489
QQ：3004930012
客服：18019219489
QQ：3004900398
电话：021-58979353
电话：021-68920155
电话：021-68404353
邮箱：info@zzsrm.com
邮箱：tech@zzbioco.com
|
|
|
| 产品中心当前位置：首 页 > 产品中心 > 全部产品 |
| 货号 |
中文名称 |
CAS编号 |
产品规格 |
价格 |
货期 |
| ZUP-1A19370 |
N-Benzoyl-2'-deoxy-2'-methylenecytidine 3',5'-Dibenzoate (25 mg) ((2R,3S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-methylenetetrahydrofuran-3-yl benzoate) |
[863329-63-9] |
1unit |
8750 |
约6周 |
|
| ZUP-1A08030 |
rac伊曲康唑丙基类似物 USP标准品 |
[74855-91-7] |
1unit |
8750 |
约6周 |
|
| ZUP-1A13320 |
Hydrocortisone 21-Butyrate (25 mg) (11Beta,17-Dihydroxy-3,20-dioxopregna-4-en-21-yl butyrate) |
[6677-99-2] |
1unit |
8750 |
约6周 |
|
| ZUP-1A08710 |
盐酸曲马多1,2-烯烃 USP标准品 |
[66170-32-9] |
1unit |
8750 |
约6周 |
|
| ZUP-1800144 |
N-Acetyl Nintedanib USP标准品 |
[64190-82-5] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15350 |
Descyclopropyl Lenvatinib (25 mg) (4-(3-chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide) |
[417719-51-8] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15340 |
Lenvatinib Acid (25 mg) (4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid) |
[417717-21-6] |
1unit |
8750 |
约6周 |
|
| ZUP-1A04640 |
糠酸替卡比松 USP标准品 |
[397864-58-3] |
1unit |
8750 |
约6周 |
|
| ZUP-1A12940 |
Desisopropyl Selexipag (25 mg) (2-{4-[(5,6-Diphenylpyrazin-2-yl)amino]butoxy}-N-(methylsulfonyl)acetamide) |
[2928611-22-5] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15840 |
(2-fluorophenyl)-1H-pyrrol-3-yl Vonoprazan (25 mg) (N,N-Bis{[5-(2-fluorophenyl)-1H-pyrrol-3-yl]methyl}-3-pyridinesulfonamide) |
[2514957-29-8] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15620 |
Descyano Tofacitinib Methylene Dimer (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione) |
[2504210-41-5] |
1unit |
8750 |
约6周 |
|
| ZUP-1A20770 |
Desoxomorpholine N-Acetyl Rivaroxaban (25 mg) (N-{[(5S)-3-(4-Acetamidophenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}-5-chloro-2-thiophenecarboxamide) |
[2422046-61-3] |
1unit |
8750 |
约6周 |
|
| ZUP-1A13620 |
Nintedanib Dimer (25 mg) (Dimethyl 3,3'-{[({[2,2'-(piperazine-1,4-diyl)bis(acetyl)]bis(methylazanediyl)}bis(4,1-phenylene))bis(azanediyl)]bis(phenylmethaneylylidene)}(3Z,3'Z)-bis(2-oxo-2,3-dihydro-1H-indole-6-carboxylate)) |
[2410284-90-9] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15400 |
Brexpiprazole Di-N-Oxide (25 mg) (7-[4-[4-(1-benzothiophen-4-yl)-1,4-dioxidopiperazine-1,4-diium-1-yl]butoxy]-1H-quinolin-2-one) |
[2247155-42-4] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15610 |
N-Formyl Tofacitinib (25 mg) ((3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinecarbaldehyde) |
[2227199-28-0] |
1unit |
8750 |
约6周 |
|
| ZUP-1A21030 |
Benzylezetimibe ether (25 mg) ((3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)propyl)azetidin-2-one) |
[204589-96-8] |
1unit |
8750 |
约6周 |
|
| ZUP-1A07640 |
加兰他敏N-氧化物 USP标准品 |
[199014-26-1] |
1unit |
8750 |
约6周 |
|
| ZUP-1A12900 |
Dolutegravir Open Ring (25 mg) ((R)-N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide) |
[1973402-05-9] |
1unit |
8750 |
约6周 |
|
| ZUP-1A08020 |
伊曲康唑二碘氧戊环类似物 USP标准品 |
[1864823-92-6] |
1unit |
8750 |
约6周 |
|
| ZUP-1A20160 |
Quetiapine Acyl Dimer (25 mg) (2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethyl 2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]acetate) |
[1798840-31-9] |
1unit |
8750 |
约6周 |
|
| ZUP-1A10200 |
Levocarnitine Tartrate USP标准品 |
[1642576-88-2] |
1unit |
8750 |
约6周 |
|
| ZUP-1A15390 |
Bisbenzothiophenyl Piperazine (25 mg) (1,4-Bis(benzo[b]thiophen-4-yl)piperazine) |
[1420987-86-5] |
1unit |
8750 |
约6周 |
|
| ZUP-1A20190 |
Quetiapine Tetraethylene Glycol (25 mg) (2-[2-(2-{2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethoxy)ethoxy]ethan-1-ol) |
[1356906-17-6] |
1unit |
8750 |
约6周 |
|
| ZUP-1A06010 |
4-（吡啶-2-基）苯甲醛 USP标准品 |
[127406-56-8] |
1unit |
8750 |
约6周 |
|
| ZUP-1A14460 |
Pinanediolyl Ixazomib (25 mg) (2,5-Dichloro-N-[2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]benzamide) |
[1201903-02-7] |
1unit |
8750 |
约6周 |
|
| ZUP-1105315 |
菊苣酸 USP标准品 |
[70831-56-0] |
1unit |
8736 |
约6周 |
|
| ZUP-1A00120 |
氟雄甾二烯羧酸 USP标准品 |
[37927-01-8] |
1unit |
8736 |
约6周 |
|
| ZUP-1A02390 |
甘露醇氨氯地平 USP标准品 |
[3085658-75-6] |
1unit |
8736 |
约6周 |
|
| ZUP-1A19690 |
Formyl Dasatinib (25 mg) (N-(2-Chloro-6-methylphenyl)-2-{[6-(4-formyl-1-piperazinyl)-2-methyl-4-pyrimidinyl]amino}-1,3-thiazole-5-carboxamide) |
[2112837-79-1] |
1unit |
8736 |
约6周 |
|
| ZUP-1A19720 |
Dasatinib Ethyl Carbamate (25 mg) (Ethyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]thiazol-2-yl}amino)-2-methylpyrimidin-4-yl]piperazine-1-carboxylate) |
[2102305-20-2] |
1unit |
8736 |
约6周 |
|
| ZUP-1A01840 |
异丁基戊二酰胺 USP标准品 |
[181289-15-6] |
1unit |
8736 |
约6周 |
|
| ZUP-1A00160 |
脱羧左氧氟沙星 USP标准品 |
[178964-53-9] |
1unit |
8736 |
约6周 |
|
| ZUP-1A01960 |
左旋氨氯地平 USP标准品 |
[103129-82-4] |
1unit |
8736 |
约6周 |
|
| ZUP-1A00990 |
脱羧莫西沙星 USP标准品 |
[1322062-57-6] |
1unit |
8736 |
约6周 |
|
| ZUP-1A07850 |
培哚普利乙内酰脲 USP标准品 |
[N/A] |
1unit |
8722 |
约6周 |
|
| ZUP-1A16990 |
Binimetinib Isomer (25 mg) (6-((4-bromo-2-fluorophenyl)amino)-7-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-5-carboxamide) |
[3110019-40-1] |
1unit |
8708 |
约6周 |
|
| ZUP-1059058 |
苄非他明相关化合物 E USP标准品 |
[1591807-86-1] |
1unit |
8708 |
约6周 |
|
| ZUP-1059069 |
苄非他明相关化合物 F USP标准品 |
[1591761-34-0] |
1unit |
8708 |
约6周 |
|
| ZUP-1A09390 |
N-Nitroso N-Desmethyl Cabergoline Solution (1 mL (1 mg/mL)) ((6aR,9R,10aR)-7-allyl-N-(ethylcarbamoyl)-N-(3-(methyl(nitroso)amino)propyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide) |
[N/A] |
1unit |
8694 |
约6周 |
|
| ZUP-1A17030 |
Descyclopropyl Cabozantinib Urea Dimer (25 mg) (1,3-bis[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]urea) |
[2840522-81-6] |
1unit |
8694 |
约6周 |
|
| ZUP-1A21240 |
Loteprednol Etabonate Methyl Ester (25 mg) (Chloromethyl (11beta,17alpha)-17-[(methoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate) |
[265651-89-6] |
1unit |
8694 |
约6周 |
|
| ZUP-1A17040 |
Desfluorophenylamine Cabozantinib Methyl Ester (25 mg) (methyl 1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylate) |
[1584696-82-1] |
1unit |
8694 |
约6周 |
|
| ZUP-1A19870 |
Desbutynyl Desaminopyridinyl Linagliptin Bromide (25 mg) (8-Bromo-3,9-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione) |
[2428491-17-0] |
1unit |
8680 |
约6周 |
|
| ZUP-1A20050 |
N-Methyl Tofacitinib Amine (25 mg) (N-[(3R,4R)-1,4-Dimethylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine) |
[2227197-38-6] |
1unit |
8680 |
约6周 |
|
| ZUP-1A11150 |
PLG 75:25 DLLG 7E USP标准品 |
[2088032-78-2] |
1unit |
8680 |
约6周 |
|
| ZUP-1A19520 |
Desacetamide Apremilast (25 mg) ((S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione) |
[2077897-93-7] |
1unit |
8680 |
约6周 |
|
| ZUP-1A15210 |
Dabigatran Benzamide Ethyl Ester (25 mg) (Ethyl 3-{2-[((4-carbamoylphenyl)amino)methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido}propanoate) |
[1422435-41-3] |
1unit |
8680 |
约6周 |
|
| ZUP-1A17200 |
N-Demethyl Imatinib Dimer (25 mg) (4,4'-(piperazine-1,4-diylbis(methylene))bis(N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide)) |
[1365802-18-1] |
1unit |
8680 |
约6周 |
|
| ZUP-1711461 |
维替泊芬 USP标准品 |
[129497-78-5] |
1unit |
8680 |
约6周 |
|
| ZUP-1483505 |
危险品；盐酸心得平 USP标准品 |
[6452-73-9] |
1unit |
8670 |
约6周 |
|
|
| |
| 共 13444 条信息 | 57-269页 |
首页 上一页 下一页 尾页 |
转到：
|
|
|
|
沪公网安备 31011202005009号